SCHEDULE 13G

Company

Aptose Biosciences Inc.

Filed

March 5, 2009

Accession Number

0001204459-09-000357

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →